<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestnik-msal</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Университета имени О.Е. Кутафина (МГЮА)</journal-title><trans-title-group xml:lang="en"><trans-title>Courier of Kutafin Moscow State Law University (MSAL))</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-5998</issn><issn pub-type="epub">2782-6163</issn><publisher><publisher-name>Московский государственный юридический университет имени О.Е. Кутафина (МГЮА)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17803/2311-5998.2017.34.6.042-053</article-id><article-id custom-type="elpub" pub-id-type="custom">vestnik-msal-144</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВЕКТОР ЮРИДИЧЕСКОЙ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>VECTOR OF LEGAL SCIENCE</subject></subj-group></article-categories><title-group><article-title>Риски и возможные последствия ограничений патентных прав в фармсфере</article-title><trans-title-group xml:lang="en"><trans-title>THE RISKS AND POSSIBLE CONSEQUENCES OF THE LIMITATIONS OF PATENT RIGHTS IN THE PHARMACEUTICAL SECTOR</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ворожевич</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorozhevich</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">arinavorozhevich@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университет имени О.Е. Кутафина</institution></aff><aff xml:lang="en"><institution>Kutafin Moscow State Law University (MSAL)</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>03</month><year>2020</year></pub-date><volume>0</volume><issue>6</issue><fpage>42</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ворожевич А.С., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Ворожевич А.С.</copyright-holder><copyright-holder xml:lang="en">Vorozhevich A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestnik.msal.ru/jour/article/view/144">https://vestnik.msal.ru/jour/article/view/144</self-uri><abstract><p>Федеральная антимонопольная служба выступила с предложением распространить институт принудительного лицензирования на фармакологические препараты. Автор статьи доказывает, что принятие подобных инициатив чревато для российской фарминдустрии существенными негативными последствиями. Оценивается возможное влияние практики принудительного лицензирования на инвестиции в фармсферу, готовность крупных фармацевтических компаний регистрировать новые лекарства в государствах с низким уровнем патентной охраны.</p></abstract><trans-abstract xml:lang="en"><p>The Federal Antimonopoly Service made a proposal to extend the compulsory licensing to pharmaceuticals. The author of the article proves that the legislative initiatives of our Antitrust Service can have strong side effects on our pharma industry. She examines the interrelationship between the issuance of compulsory licenses for essential medicines and the influx of FDI, incentives of «Big pharma» to register new drugs in countries with a low level of patent protection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>принудительная лицензия</kwd><kwd>патентные права</kwd><kwd>фармацевтические препараты</kwd><kwd>Соглашение ТРИПС</kwd><kwd>Федеральная антимонопольная служба</kwd></kwd-group><kwd-group xml:lang="en"><kwd>compulsory license</kwd><kwd>patent rights</kwd><kwd>pharmaceuticals</kwd><kwd>TRIPS Agreement</kwd><kwd>Federal Antimonopoly Service</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">URL: http://www.pharmvestnik.ru/publs/lenta/v-rossii/proekt-po-prinuditeljnomu-litsen-zirovaniju.html#.WGti0fmLTDd</mixed-citation><mixed-citation xml:lang="en">URL: http://www.pharmvestnik.ru/publs/lenta/v-rossii/proekt-po-prinuditeljnomu-litsen-zirovaniju.html#.WGti0fmLTDd</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Игорь Артемьев: ФАС предлагает использовать самый щадящий вариант принудительного лицензирования // URL: http://www.pharmvestnik.ru/publs/lenta/v-rossii/igorj-artemjev-fas-predlagaet-ispoyzovatj-samyj-schadjaschij-variant-prinuditeljnogo.html#.V-A47fCLTDc.</mixed-citation><mixed-citation xml:lang="en">Игорь Артемьев: ФАС предлагает использовать самый щадящий вариант принудительного лицензирования // URL: http://www.pharmvestnik.ru/publs/lenta/v-rossii/igorj-artemjev-fas-predlagaet-ispoyzovatj-samyj-schadjaschij-variant-prinuditeljnogo.html#.V-A47fCLTDc.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">URL: http://regulation.gov.ru/projects/List/AdvancedSearch#npa=46586.</mixed-citation><mixed-citation xml:lang="en">URL: http://regulation.gov.ru/projects/List/AdvancedSearch#npa=46586.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">URL: http://regulation.gov.ru/projects/List/AdvancedSearch#npa=46586.</mixed-citation><mixed-citation xml:lang="en">URL: http://regulation.gov.ru/projects/List/AdvancedSearch#npa=46586.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Letter from Francis C. Collins, Director, NIH, to Andrew S. Goldman, Knowledge Ecology International, June 20, 2016 // URL: http://keionline.org/sites/default/files/Final-Response-Goldman-6.20.2016.pdf.</mixed-citation><mixed-citation xml:lang="en">Letter from Francis C. Collins, Director, NIH, to Andrew S. Goldman, Knowledge Ecology International, June 20, 2016 // URL: http://keionline.org/sites/default/files/Final-Response-Goldman-6.20.2016.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Orlhac T. The new canadian pharmaceutical compulsory licensing provisions or how to jump out of the frying pan and into the fire // URL: http://www.robic.ca/admin/pdf/514/167E-TO.pdf.</mixed-citation><mixed-citation xml:lang="en">Orlhac T. The new canadian pharmaceutical compulsory licensing provisions or how to jump out of the frying pan and into the fire // URL: http://www.robic.ca/admin/pdf/514/167E-TO.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Braga C., Fink C. The relationship between intellectual property rights and foreign direct investment // Duke Journal Of Comparative &amp; International Law. Vol. 9. № 163.</mixed-citation><mixed-citation xml:lang="en">Braga C., Fink C. The relationship between intellectual property rights and foreign direct investment // Duke Journal Of Comparative &amp; International Law. Vol. 9. № 163.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J. Y., Mansfield E. Intellectual Property Protection and U.S. Foreign Direct Investment // The Review of Economics and Statistics. 1996. Vol. 78. Issue 2. P. 181.</mixed-citation><mixed-citation xml:lang="en">Lee J. Y., Mansfield E. Intellectual Property Protection and U.S. Foreign Direct Investment // The Review of Economics and Statistics. 1996. Vol. 78. Issue 2. P. 181.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bird R., Cahoy D. The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach // American Business Law Journal. 2008. Vol. 45. Issue 2.</mixed-citation><mixed-citation xml:lang="en">Bird R., Cahoy D. The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach // American Business Law Journal. 2008. Vol. 45. Issue 2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Фармацевтический рынок России. Итоги 2015 // Annual report 2015 DSM GROUP URL: http://www.dsm.ru/docs/analytics/Annual_report_2015_DSM_web.pdf.</mixed-citation><mixed-citation xml:lang="en">Фармацевтический рынок России. Итоги 2015 // Annual report 2015 DSM GROUP URL: http://www.dsm.ru/docs/analytics/Annual_report_2015_DSM_web.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Медицинское признание // Ведомости. 17.01.2016. URL: http://www.vedomosti.ru/ newspaper/articles/2016/01/17/624308-meditsinskoe-priznanie</mixed-citation><mixed-citation xml:lang="en">Медицинское признание // Ведомости. 17.01.2016. URL: http://www.vedomosti.ru/ newspaper/articles/2016/01/17/624308-meditsinskoe-priznanie</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Braga C., Fink C. The relationship between intellectual property rights and foreign direct investment // Duke Journal Of Comparative &amp; International Law. - 1998. - Vol. 9. - № 163.</mixed-citation><mixed-citation xml:lang="en">Braga C., Fink C. The relationship between intellectual property rights and foreign direct investment // Duke Journal Of Comparative &amp; International Law. - 1998. - Vol. 9. - № 163.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bird R., Cahoy D. The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach // American Business Law Journal. - 2008. - Vol. 45. - Issue. 2.</mixed-citation><mixed-citation xml:lang="en">Bird R., Cahoy D. The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach // American Business Law Journal. - 2008. - Vol. 45. - Issue. 2.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.Y., Mansfield E. Intellectual Property Protection and U.S. Foreign Direct Investment // The Review of Economics and Statistics. - 1996. - Vol. 78. - Issue 2. 19</mixed-citation><mixed-citation xml:lang="en">Lee J.Y., Mansfield E. Intellectual Property Protection and U.S. Foreign Direct Investment // The Review of Economics and Statistics. - 1996. - Vol. 78. - Issue 2. 19</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
